About us Contacts Drug interactions: 390 212
Drug search by name

Hycamtin (Topotecan Capsules) and Xpovio (80 MG Twice Weekly)

Determining the interaction of Hycamtin (Topotecan Capsules) and Xpovio (80 MG Twice Weekly) and the possibility of their joint administration.

Check result:
Hycamtin (Topotecan Capsules) <> Xpovio (80 MG Twice Weekly)
Relevance: 05.07.2022 Reviewer: Shkutko P.M., M.D., in

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer:

Consumer information for this interaction is not currently available.MONITOR: The use of topotecan with other cytotoxic agents is likely to result in greater myelosuppression due to additive or synergistic pharmacologic effects. Severe neutropenia and neutropenic sepsis resulting in death were reported with topotecan and cisplatin. MANAGEMENT: Caution is advised if topotecan is used with other cytotoxic agents. Dosage reductions may be required, and bone marrow function should be closely monitored. Patients should be advised to contact their physician if they develop signs and symptoms of myelosuppression such as pallor, dizziness, fatigue, lethargy, fainting, easy bruising or bleeding, or signs of infection such as fever, chills, sore throat, body aches, and other influenza-like symptoms. References "Product Information. Hycamtin (topotecan)." SmithKline Beecham, Philadelphia, PA.

Professional:

MONITOR: The use of topotecan with other cytotoxic agents is likely to result in greater myelosuppression due to additive or synergistic pharmacologic effects. Severe neutropenia and neutropenic sepsis resulting in death were reported with topotecan and cisplatin.

MANAGEMENT: Caution is advised if topotecan is used with other cytotoxic agents. Dosage reductions may be required, and bone marrow function should be closely monitored. Patients should be advised to contact their physician if they develop signs and symptoms of myelosuppression such as pallor, dizziness, fatigue, lethargy, fainting, easy bruising or bleeding, or signs of infection such as fever, chills, sore throat, body aches, and other influenza-like symptoms.

References
  • "Product Information. Hycamtin (topotecan)." SmithKline Beecham, Philadelphia, PA.
Hycamtin (Topotecan Capsules)

Generic Name: topotecan

Brand name: Hycamtin

Synonyms: Hycamtin (oral/injection), Hycamtin

Xpovio (80 MG Twice Weekly)

Generic Name: selinexor

Brand name: Xpovio

Synonyms: Xpovio

In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.